MIVI Neuroscience Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
40
- Latest Deal Type
-
2ndary - Private
- Investors
-
5
MIVI Neuroscience General Information
Description
Operator of a clinical company intended to develop and commercialize clinical services for neuro-interventional procedures. The company's product portfolio provides physicians with unique devices to improve the safety and efficacy of interventional AIS therapy, enabling healthcare professionals to improve patient outcomes by reducing complications, shortening procedure times, and expanding treatment to more patients.
Contact Information
Website
www.mivineuro.comCorporate Office
- 6545 City West Parkway
- Eden Prairie, MN 55344
- United States
Corporate Office
- 6545 City West Parkway
- Eden Prairie, MN 55344
- United States
MIVI Neuroscience Timeline
MIVI Neuroscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 13. Mezzanine | 24-May-2024 | Completed | Generating Revenue | |||
| 12. Later Stage VC | 14-Jul-2023 | Completed | Generating Revenue | |||
| 11. Later Stage VC (Series B) | 29-Dec-2020 | Completed | Generating Revenue | |||
| 10. Debt - PPP | 01-May-2020 | Completed | Pre-Clinical Trials | |||
| 9. Later Stage VC | 14-May-2019 | Completed | Pre-Clinical Trials | |||
| 8. Later Stage VC (Series A) | 07-Feb-2019 | Completed | Pre-Clinical Trials | |||
| 7. Later Stage VC | 04-Dec-2018 | Completed | Startup | |||
| 6. Seed Round | 08-Aug-2018 | $1.7M | $11.9M | Completed | Startup | |
| 5. Seed Round | 07-Sep-2017 | $1.64M | $10.2M | Completed | Startup |
MIVI Neuroscience Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-2 | ||||||||
| Series B-1 | ||||||||
| Series B | ||||||||
| Series A | ||||||||
| Seed-3 | ||||||||
| Seed-2 | 725,020 | $0.000010 | $10.14 | $10.14 | 1x | $10.14 | 4.74% | |
| Seed | 138,562 | $0.000010 | $8.58 | $8.58 | 1x | $8.58 | 0.91% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
MIVI Neuroscience Comparisons
Industry
Financing
Details
MIVI Neuroscience Competitors (23)
One of MIVI Neuroscience’s 23 competitors is B. Braun, a Corporation company based in Melsungen, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| B. Braun | Corporation | Melsungen, Germany | ||||
| Phenox | Formerly PE-Backed | Bochum, Germany | ||||
| Elixir Medical | Venture Capital-Backed | Milpitas, CA | ||||
| Imperative Care | Venture Capital-Backed | Campbell, CA | ||||
| Vygon (uk) Ltd. | Corporation | Hilton Head Island, SC |
MIVI Neuroscience Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
MIVI Neuroscience Patents
MIVI Neuroscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024258726-A2 | An embolic protection device designed in particular for tortuous blood vessels, especially cerebral vessels | Inactive | 13-Jun-2023 | ||
| WO-2024258726-A3 | An embolic protection device designed in particular for tortuous blood vessels, especially cerebral vessels | Inactive | 13-Jun-2023 | ||
| WO-2024129972-A2 | Catheters with laser cut hypotube scaffold for flow under significant pressure differentials | Inactive | 15-Dec-2022 | ||
| WO-2024129972-A3 | Catheters with laser cut hypotube scaffold for flow under significant pressure differentials | Inactive | 15-Dec-2022 | ||
| WO-2024112693-A1 | Rapid clot removal using aspiration catheter with aspiration guided by monitoring aspiration performance | Inactive | 21-Nov-2022 | A61B17/22 |
MIVI Neuroscience Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
MIVI Neuroscience Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Philips Ventures | Corporate Venture Capital | |||
| Aphelion Capital | Venture Capital | Minority | ||
| Concord Health Partners | Growth/Expansion | Minority | ||
| Angel (individual) | Minority | |||
| Deerfield Management | Venture Capital | Minority |
MIVI Neuroscience FAQs
-
When was MIVI Neuroscience founded?
MIVI Neuroscience was founded in 2013.
-
Where is MIVI Neuroscience headquartered?
MIVI Neuroscience is headquartered in Eden Prairie, MN.
-
What is the size of MIVI Neuroscience?
MIVI Neuroscience has 40 total employees.
-
What industry is MIVI Neuroscience in?
MIVI Neuroscience’s primary industry is Other Healthcare Services.
-
Is MIVI Neuroscience a private or public company?
MIVI Neuroscience is a Private company.
-
What is MIVI Neuroscience’s current revenue?
The current revenue for MIVI Neuroscience is .
-
How much funding has MIVI Neuroscience raised over time?
MIVI Neuroscience has raised $79.7M.
-
Who are MIVI Neuroscience’s investors?
Philips Ventures, Aphelion Capital, Concord Health Partners, , and Deerfield Management have invested in MIVI Neuroscience.
-
Who are MIVI Neuroscience’s competitors?
B. Braun, Phenox, Elixir Medical, Imperative Care, and Vygon (uk) Ltd. are some of the 23 competitors of MIVI Neuroscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
